Use of a COPD care pathway heightened the odds for a pulmonary rehabilitation referral and home discharge in hospitalized ...

Adults hospitalized for acute COPD exacerbation faced elevated odds for all-cause mortality and ICU admission if they had end-stage renal disease and were on dialysis, according to data presented at ...

The World Health Organization says chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death ...

Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading ...

Biologic therapies targeting eosinophilic inflammation hold promise for COPD management. Realising their benefits will ...

Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...

The small-profile device expands to capture clots like large-bore systems while offering good reduction in RV/LV ratio at 48 ...

ERS 2025 covered lung cancer treatment advances like robot-assisted bronchoscopy with integrated cone-beam CT (RAB-CBCT) and ...

Key points A 53-year-old woman with rectosigmoid adenocarcinoma was seen in the radiation oncology clinic for her fifth and final fraction of neoadjuvant radiotherapy, where she reported chills, ...

Q2 2026 Earnings Call November 14, 2025 4:30 PM ESTCompany ParticipantsWaqaas Al-Siddiq - Founder, President, CEO ...

A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...

Savara Inc. (NASDAQ:SVRA) is one of the top long-term biotechnology stocks to buy. On October 2, Savara Inc. (NASDAQ:SVRA) announced that its partner, TrilliumBiO, will present data on the development ...